SLC7A11 and neoplasm: Specifically, GNA modulates the P53/SLC7A11/GSH/GPX4 axis, resulting in GSH depletion, elevated ROS, and mitochondrial dysfunction, with in vivo studies confirming its efficacy in suppressing tumor growth [162].